Company
Headquarters: Beijing, China
Employees: 3,005
CN¥21.87 Billion
CNY as of July 1, 2025
US$3.05 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.
| Last Financial Reports Date | March 31, 2025 |
| Revenue TTM | CN¥51.19 B |
| EBITDA | CN¥2.75 B |
| Gross Profit TTM | CN¥3.54 B |
| Profit Margin | 3.91% |
| Operating Margin | 3.80% |
| Quarterly Revenue Growth | 4.90% |
China National Medicines Corp Ltd has the following listings and related stock indices.
Stock: SSE: 600511 wb_incandescent